SCHEMBL7095053

SCHEMBL7095053

O=C(CC1CCC=CCN1)OCc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
GLA P06280 1/20 0.53
ALDH1A1 P00352 4/20 0.45
MAPK1 P28482 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
TSHR P16473 2/20 0.39
KMT2A Q03164 2/20 0.39
SLC6A2 P23975 1/20 0.39
SLC6A3 Q01959 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
HTR2C P28335 1/20 0.39
GAA P10253 1/20 0.39
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9038558 0.80 GLA (0.60) GLAALDH1A1MAPK1L3MBTL1TSHR
SCHEMBL9060376 0.78 GLA (0.59) GLAALDH1A1MAPK1L3MBTL1TSHR
SCHEMBL5971142 0.78 TSHR (0.52) GLAALDH1A1MAPK1L3MBTL1SMN1; SMN2
SCHEMBL27856601 0.76 GLA (0.53) GLAALDH1A1MAPK1L3MBTL1SMN1; SMN2
SCHEMBL4143101 0.74 ALDH1A1 (0.59) GLAALDH1A1MAPK1L3MBTL1SMN1; SMN2
Trifluoroacetic Acid SCHEMBL9037494 0.73 GLA (0.53) GLAALDH1A1MAPK1L3MBTL1KMT2A
SCHEMBL11203745 0.73 GLA (0.59) GLAALDH1A1MAPK1L3MBTL1KMT2A
SCHEMBL25216322 0.73 GLA (0.52) GLAALDH1A1MAPK1L3MBTL1SMN1; SMN2
SCHEMBL3393626 0.73 GLA (0.62) GLAALDH1A1MAPK1L3MBTL1SMN1; SMN2
SCHEMBL29059492 0.73 GLA (0.55) GLAALDH1A1MAPK1L3MBTL1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1278502-A4 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORP (US) 2003-05-21 EP disclosed
EP-1278502-A2 PROTEASE INHIBITORS SmithKline Beecham Corporation (US) 2003-01-29 EP disclosed
WO-2001089451-A2 PROTEASE INHIBITORS SMITHKLINE BEECHAM CORPORATION (US) 2001-11-29 WO disclosed